Skip to main content
Journal of Nanobiotechnology logoLink to Journal of Nanobiotechnology
. 2026 Aug 19;24:779. doi: 10.1186/s12951-026-04925-x

Correction: Reversing the immunosuppressive microenvironment with reduced redox level by microwave-chemo-immunostimulant Ce-Mn MOF for improved immunotherapy

Zhiheng Zeng 1,2,3, Changhui Fu 1,2,, Xiaohan Sun 4, Meng Niu 4, Xiangling Ren 1,2, Longfei Tan 1,2, Qiong Wu 1,2, Zhongbing Huang 3,, Xianwei Meng 1,2,
PMCID: PMC13488196  PMID: 42618918

Correction: Journal of Nanobiotechnology (2022) 20:512

10.1186/s12951-022-01699-w

In this article Fig. 8 appeared incorrectly and has now been corrected in the original publication. In Fig. 8f, the representative tissue section image of the tumor for CMMCP + MW group was inadvertently replaced with image from other group. For completeness and transparency, the correct and incorrect versions are displayed below.

Fig. 8.

Fig. 8

Biocompatibility and antitumor activity of CMMCP in vivo. a H&E staining sections of heart, liver, spleen, lung, kidney from mice injected CMMP intravenously at 200 mg/kg and control group. b Body weight changes of mice with injection of CMMP at different doses (0, 50, 100, and 200 mg/kg) within 14 days. c Body weight changes of mice from the control group, MW, CDDP, CMMCP and CMMCP + MW groups during the 14-day treatment period. d Tumor volume growth curve in each experimental group for 14 days. e Images of tumors in different groups after 14 days. f H&E staining sections of tumor slices for different groups killed at 14 days. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001

Incorrect Fig. 8.

Correct Fig. 8.

Fig. 8.

Fig. 8

Biocompatibility and antitumor activity of CMMCP in vivo. a H&E staining sections of heart, liver, spleen, lung, kidney from mice injected CMMP intravenously at 200 mg/kg and control group. b Body weight changes of mice with injection of CMMP at different doses (0, 50, 100, and 200 mg/kg) within 14 days. c Body weight changes of mice from the control group, MW, CDDP, CMMCP and CMMCP + MW groups during the 14-day treatment period. d Tumor volume growth curve in each experimental group for 14 days. e Images of tumors in different groups after 14 days. f H&E staining sections of tumor slices for different groups killed at 14 days. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001

The original article has been corrected.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Changhui Fu, Email: fuchanghui@mail.ipc.ac.cn.

Zhongbing Huang, Email: zbhuang@scu.edu.cn.

Xianwei Meng, Email: mengxw@mail.ipc.ac.cn.


Articles from Journal of Nanobiotechnology are provided here courtesy of BMC

RESOURCES